Faran S.A. and Meiji

News and Announcements

Posted in Collaborations, Pulmology

Faran S.A. is pleased to announce its collaboration with the Japanese pharmaceutical company MEIJI in the field of infections, which concerns the launch in the Greek market of the original pharmaceutical product Spectracef (Ceftidoren Pivoxil).

Spectracef (Ceftidoren Pivoxil) is a 3rd generation oral cephalosporin, a research product of the company MEIJI for the treatment of community respiratory infections, as well as uncomplicated soft tissue infections.